Skip navigation

Sinopharm Group Co. Ltd.

Pharmaceuticals
China
2016 Revenue (US$ Millions)$37,210
Revenue Growth (%)13.79%
Net Income (US$ Millions)$669
Earnings Per Share (US$)$0.24
EPS Growth Rate (%)23.53%
Profit Margin1.80%
Total Equity (US$ Millions)$4,581
Return on Equity (%)15.46%
Long Term Debt (US$ Millions)$1,604
Debt To Equity Ratio (%)0.35%
Total Assets (US$ Millions)$22,712
Current Assets (US$ Millions)$19,118
Current Liabilities (US$ Millions)$14,363
Cost of Goods Sold (US$ Millions)$34,233
Inventory Turnover9.88